We are advancing AI to power the future of medicine. At Unlearn, our purpose is to advance artificial intelligence (AI) to eliminate trial and error in medicine. We are innovating advanced machine learning methods to leverage generative AI in forecasting patient outcomes, starting with the domain of clinical trials. We produce AI-generated digital twins of individual trial participants, enabling smaller and more efficient clinical trials to bring effective medicines to patients sooner. Our innovative work in AI today will reinvent how AI is applied in medicine tomorrow — and we have a top secret plan for how to get there. We won’t be able to achieve this mission just by applying technologies created by others; the future must be invented. Unlearn is a technology company, not a biotech company. We use computers, not pipettes. We make and use software, we don’t discover or make drugs. We believe that AI will define the future of medicine, and we aren’t deterred by naysayers or skeptics. We come from a variety of backgrounds ranging from machine learning to marketing—but regardless of where we come from, Unlearners share some common traits: Unlearners are ambitious; we aren’t intimidated by big, challenging goals. Unlearners are disciplined experimenters; we break down our big goals into smaller chunks and meet as often as necessary to track our velocity and iterate quickly. Unlearners are gritty; we never give up, setbacks just make us try harder. Unlearners are receptive to new ideas; in fact, we hate being stuck with the status quo Unlearners are storytellers; sharing information with each other and with the world is super important, too important to be boring. And, last but not least, Unlearners are team-oriented; we put the mission first, the company second, the team third, and individuals last. Headquartered in San Francisco, Unlearn was founded in 2017 by a team of world-class machine learning scientists. We have raised venture capital from top tier investors such as Altimeter, Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio, and recently completed our $50 million Series C in January 2024. If our purpose and culture resonate with you, we invite you to apply. The Role We are seeking a Finance Manager, FP&A who will play a critical role in supporting budgeting, forecasting, financial modeling, and operational reporting across the company. This is a highly hands-on role, and you should be excited to build models, analyze data, prepare reporting packages, and support decision-making across multiple teams. You’ll report to our CFO and work closely with the Senior Finance team, Commercial, Product, and Operations stakeholders. The ideal candidate is analytical, detail-oriented, strong in Excel/Google Sheets, and eager to take ownership of recurring financial processes as well as ad hoc projects.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Education Level
No Education Listed
Number of Employees
51-100 employees